Jamie Brannan serves as the Executive Vice President and Chief Commercial Officer at Zoetis Inc Class A, a leading animal health company. With a robust background in the pharmaceutical and animal health industries, Brannan has been instrumental in driving Zoetis' commercial strategy and growth. Prior to joining Zoetis in 2011, Brannan held several key leadership positions at Pfizer, where she honed her skills in sales, marketing, and business development. Her transition to Zoetis coincided with the company's spin-off from Pfizer, and she played a pivotal role in establishing Zoetis as an independent entity. In her role as Chief Commercial Officer, Brannan oversees global sales and marketing operations, ensuring that Zoetis continues to meet the needs of veterinarians, livestock producers, and pet owners worldwide. Under her leadership, Zoetis has successfully launched several innovative products, such as Simparica Trio and Librela, which have significantly expanded the company's portfolio and market presence. Brannan's strategic vision and deep understanding of the animal health market have been crucial in navigating the competitive landscape and fostering sustainable growth. Her commitment to excellence and innovation has earned her recognition within the industry and solidified her reputation as a dynamic leader. Brannan's achievements extend beyond her corporate role, as she is actively involved in industry associations and initiatives aimed at advancing animal health and welfare. She serves on the board of directors for the Animal Health Institute and is a frequent speaker at industry conferences, sharing insights on market trends and future opportunities in the animal health sector. Her dedication to mentoring the next generation of leaders and her passion for improving animal health globally continue to drive her work at Zoetis and beyond.